Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents

J Med Chem. 2003 Mar 27;46(7):1081-111. doi: 10.1021/jm020450x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Drug Resistance
  • Endometrial Neoplasms / chemically induced
  • Estradiol Congeners / adverse effects
  • Estrogen Receptor Modulators / chemistry
  • Estrogen Receptor Modulators / pharmacology
  • Estrogen Receptor Modulators / therapeutic use
  • Estrogen Receptor alpha
  • Estrogen Receptor beta
  • Female
  • Humans
  • Models, Molecular
  • Osteoporosis, Postmenopausal / prevention & control
  • Raloxifene Hydrochloride / adverse effects
  • Raloxifene Hydrochloride / pharmacology
  • Raloxifene Hydrochloride / therapeutic use
  • Receptors, Estrogen / drug effects
  • Selective Estrogen Receptor Modulators / chemistry
  • Selective Estrogen Receptor Modulators / pharmacology*
  • Selective Estrogen Receptor Modulators / therapeutic use
  • Steroids / chemistry
  • Steroids / pharmacology
  • Steroids / therapeutic use
  • Structure-Activity Relationship
  • Tamoxifen / adverse effects
  • Tamoxifen / analogs & derivatives
  • Tamoxifen / pharmacology
  • Tamoxifen / therapeutic use

Substances

  • Antineoplastic Agents
  • Estradiol Congeners
  • Estrogen Receptor Modulators
  • Estrogen Receptor alpha
  • Estrogen Receptor beta
  • Receptors, Estrogen
  • Selective Estrogen Receptor Modulators
  • Steroids
  • Tamoxifen
  • Raloxifene Hydrochloride